Celcuity Inc.
🏢 View company profile →9Patents
9Active
9Granted
48Portfolio score
Filing activity: Jan 6, 2015 → Jan 23, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9404915B2 | Whole cell assays and methods | Physics | 5 | Active |
| US10041934B2 | Whole cell assays and methods | Physics | 4 | Active |
| US11073509B2 | Assays and methods for determining the responsiveness of an individual subject to a therapeutic agent | Physics | 3 | Active |
| US11333659B2 | Methods of measuring signaling pathway activity for selection of therapeutic agents | Physics | 2 | Active |
| US10976307B2 | Whole cell assays and methods | Physics | 2 | Active |
| US11591573B2 | Methods of preparing a primary cell sample | Chemistry; Metallurgy | 1 | Active |
| US12320799B2 | Methods of measuring signaling pathway activity for selection of therapeutic agents | Physics | 0 | Active |
| US12215356B2 | Methods of preparing a primary cell sample | Chemistry; Metallurgy | 0 | Active |
| US12350276B2 | Methods for the treatment of cancer using 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.